These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 17943879)
1. WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Al-Asfoor A; Fedorowicz Z Cochrane Database Syst Rev; 2007 Oct; (4):CD006039. PubMed ID: 17943879 [TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Al-asfoor A; Fedorowicz Z Cochrane Database Syst Rev; 2007 Jul; (3):CD006039. PubMed ID: 17636822 [TBL] [Abstract][Full Text] [Related]
3. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Al-Asfoor A; Fedorowicz Z; Lodge M Cochrane Database Syst Rev; 2008 Apr; (2):CD006039. PubMed ID: 18425932 [TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357 [TBL] [Abstract][Full Text] [Related]
5. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature. Tandan VR; Harmantas A; Gallinger S Can J Surg; 1997 Jun; 40(3):175-81. PubMed ID: 9194777 [TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation. Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609 [TBL] [Abstract][Full Text] [Related]
7. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Riemsma RP; Bala MM; Wolff R; Kleijnen J Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373 [TBL] [Abstract][Full Text] [Related]
8. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Riemsma RP; Bala MM; Wolff R; Kleijnen J Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145 [TBL] [Abstract][Full Text] [Related]
9. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Gurusamy KS; Ramamoorthy R; Sharma D; Davidson BR Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD007060. PubMed ID: 19370671 [TBL] [Abstract][Full Text] [Related]
10. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853 [TBL] [Abstract][Full Text] [Related]
13. Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial. Gurusamy K; Corrigan N; Croft J; Twiddy M; Morris S; Woodward N; Bandula S; Hochhauser D; Napp V; Pullan A; Jakowiw N; Prasad R; Damink SO; van Laarhoven CJHM; de Wilt JHW; Brown J; Davidson BR Trials; 2018 Feb; 19(1):105. PubMed ID: 29439711 [TBL] [Abstract][Full Text] [Related]
14. Hepatic surgery for metastases from neuroendocrine tumors. Sarmiento JM; Que FG Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141 [TBL] [Abstract][Full Text] [Related]
15. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Nelson R; Freels S Cochrane Database Syst Rev; 2004; (2):CD003770. PubMed ID: 15106219 [TBL] [Abstract][Full Text] [Related]